AI drug discovery company

Unnatural Products

Data as of Oct 17, 2026.

Company facts

Founded

2017

ConfirmedSource for founded (opens in new tab)
Headquarters

United States (Santa Cruz, CA)

ConfirmedSource for headquarters (opens in new tab)

Latest funding round

Round: Series B
Date: Mar 16, 2026
Amount: $45M
Lead investor: The Venture Collective (TVC)

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

1 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

Novartis Pharma

Research collaboration and license, Feb 18, 2026

$100M upfront ($1.8B total potential)

ReportedSource for Novartis (opens in new tab)

Recent news

Mar 16, 2026

Series B: $45M

ConfirmedSource (opens in new tab)
Feb 19, 2026

Novartis macrocyclic peptide partnership up to $1.8B+

ReportedSource (opens in new tab)
Feb 18, 2026

Novartis research collaboration and license deal on cardiovascular macrocycles

ReportedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.